2 completed, 1 terminated. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Somatostatinoma: new trials by email Literature Review of Somatostatinoma trials Research Report on Somatostatinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors Indium-111 pentetreotide - Neuroendocrine Tumors | Phase 2 / Phase 3 | Completed | Radio Isotope Therapy of America | 200 | 2005-08-01 | 2023-04-03 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors bevacizumab, 5-fluorouracil, leucovorin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 / Phase 3 | Terminated | University of California, San Francisco | 36 | 2005-06-08 | 2023-05-22 |
Carcinoma, Islet Cell (2) · Gastrinoma (2) · Glucagonoma (2) · Insulinoma (2) · Neoplasms (2) · Neuroendocrine Tumors (2) · Vipoma (2) · Adenoma, Islet Cell (1) · Adrenocortical Carcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Astrocytoma (1) · Bile Duct Neoplasms (1) · Blast Crisis (1)
Adenocarcinoma (3) · Carcinoma (3) · Carcinoma, Neuroendocrine (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Pancreatic Diseases (3) · Adenoma (2)
Bevacizumab (1) · Fentanyl (1) · Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1)
INSYS Therapeutics Inc (1) · Radio Isotope Therapy of America (1) · University of California, San Francisco (1)
United States (3)
Ebrahim Delpassand, M.D. (1) · Emily K. Bergsland, MD (1) · Larry Dillaha, MD (1)